Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
about
Allergen Immunotherapy: Past, Present, and FutureNew treatments for allergen immunotherapyDevelopments in the field of allergy in 2009 through the eyes of Clinical and Experimental AllergyIndoor Allergens and Allergic Respiratory DiseaseProduction of egg yolk antibodies specific to house dust mite proteinsGeneration of a chimeric dust mite hypoallergen using DNA shuffling for application in allergen-specific immunotherapy.Recombinant house dust mite allergens.Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine.Immunotherapy for house dust mite sensitivity: where are the knowledge gaps?House-dust mite allergy: mapping of Dermatophagoides pteronyssinus allergens for dogs by two-dimensional immunoblottingHypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy.Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extractsAllergy to grass pollen: mapping of Dactylis glomerata and Phleum pratense allergens for dogs by two-dimensional immunoblotting.Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives.Regulatory cells in allergen-specific immunotherapy.Recombinant allergen-based provocation testing.Approaches for the generation of active papain-like cysteine proteases from inclusion bodies of Escherichia coli.Allergen extracts for immunotherapy: to mix or not to mix?Fungal Ribotoxins: A Review of Potential Biotechnological Applications.Natural Evolution of IgE Responses to Mite Allergens and Relationship to Progression of Allergic Disease: a Review.Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model.
P2860
Q26765974-82FDA714-FE65-42E9-A37E-FFAE17E26EA3Q27016089-4B624F7B-5B96-47E6-8C8E-82DAC5A6D1E3Q28385685-5D2860C5-EE3F-4C2B-8276-26DF83FA9720Q28386020-DA364313-1D23-4436-B559-51F0804D6080Q33822620-7D034D65-D6FC-403B-B60D-783E0DE71756Q34028890-3778CB0E-193F-4D95-95F3-9D29DA5A0F21Q34361546-CFDDB7DE-81B8-4472-9515-7E6FEA2104A9Q34415246-E65C9693-1A79-4265-A019-4F6234997057Q34445398-CA0007D2-FE16-4350-BCFC-277C983A6E15Q35620553-F63B0916-2BA6-4FA3-941C-B38C3F19D357Q36125658-70653E84-80A0-400E-AF7D-958BD3EBD3D4Q36125679-AAEFDCAA-A0DC-481D-B484-A20F446BC643Q37670645-B47F795D-C9D8-41B3-85C7-48EA46DB6C9BQ37958561-3817E345-9309-4C21-84B0-D3255F1D7077Q38003474-3CD6C6E1-4667-4317-8FA0-F418078E0F94Q38127011-31E4A4BD-06D0-448C-884A-3236DDE94982Q38384737-0A97E51F-343B-475E-BE7B-011BB973DA9FQ38664847-3A9810FF-8443-4AF3-A5EA-A3665C7C1130Q39147928-06C7957A-F03F-4729-BE0A-DFD5128D7EB7Q39254046-A6AC8135-58F9-47F9-A639-EF232DB936D7Q41769755-2EF0DC36-429B-40C8-B2C0-52194DC3585BQ48273752-E41FC251-4567-40B2-9AFD-BE947977538B
P2860
Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Engineering of major house dus ...... lergen-specific immunotherapy.
@en
Engineering of major house dus ...... lergen-specific immunotherapy.
@nl
type
label
Engineering of major house dus ...... lergen-specific immunotherapy.
@en
Engineering of major house dus ...... lergen-specific immunotherapy.
@nl
prefLabel
Engineering of major house dus ...... lergen-specific immunotherapy.
@en
Engineering of major house dus ...... lergen-specific immunotherapy.
@nl
P2093
P1476
Engineering of major house dus ...... llergen-specific immunotherapy
@en
P2093
A Martínez
I Ibarrola
J A Asturias
J E Viñuela
M C Arilla
P M Gamboa
P304
P356
10.1111/J.1365-2222.2009.03264.X
P577
2009-04-21T00:00:00Z